NCT02988687View on ClinicalTrials.gov

Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Adult-Onset Growth Hormone Deficiency
Trial Locations (1)

98108

VA Puget Sound Health Care System, Seattle

All Listed Sponsors
lead

Garcia, Jose M., MD, PhD

INDIV

NCT02988687 - Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD | Biotech Hunter | Biotech Hunter